ACECLIDINE HYDROCHLORIDE | N218585 | LENZ THERAPEUTICS INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from LENZ Therapeutics FDA-2025-P-6522 LENZ Therapeutics filed this citizen petition requesting that the FDA's Division of Medication Error Prevention and Analysis evaluate and potentially require modification of the proposed proprietary names YUVEZZI or UVEZZI for the pending NDA for Brimochol PF, citing a high risk of confusion with VI | Other | 2025-11-28 | Withdrawn | LENZ Therapeutics |
Source: Regulations.gov. FDA citizen petitions matched by application number.